NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Medecins Sans Frontieres, also known as Doctors Without Borders, on Friday argued against US drug giant Pfizer's application to patent its pneumonia vaccine at the Indian patent office. Pfizer's vaccine, sold under the brand Prevnar13, should not be patented in the country because it lacks the originality needed for one,…

news

Generic competition to cholesterol buster Crestor in the U.S. market pushed second-quarter core earnings down by nearly a third at drugmaker AstraZeneca, which is now banking on new cancer medicines to revive its fortunes. The profit drop had been expected, however, and investors took heart from encouraging early sales of…

news

French drugmaker Sanofi's sales and profit fell in the second quarter despite double-digit growth at biotech arm Genzyme, as the diabetes division continued to come under sustained U.S. pricing pressure. Business net income fell 3.3 percent to 1.68 billion euros ($1.86 billion) at constant exchange rates, with revenue down 0.2…

news

U.S. biotechnology company Celgene Corp reported a 21 percent jump in quarterly revenue, driven by demand for its key multiple myeloma drug, Revlimid. Revenue rose to $2.75 billion from $2.28 billion in the second quarter ended June 30. The company's net income rose to $598.2 million, or 75 cents per…

news

Harsh Goenka-promoted RPG Life Sciences has bought seven brands of Sun Pharma at a deal value of Rs 41 crore and is expected to give RPG extra room to expand in the nearly $5 billion domestic market. Some of these drugs are part of the overlap of products from the…

news

Mylan N.V. (MYL) announced that the U.S. Federal Trade Commission ("FTC") has cleared Mylan's proposed transaction to acquire Meda Aktiebolag (publ.) subject to Mylan's divestiture of certain products not significant to Mylan's earnings following the consummation of its recommended public offer to the shareholders of Meda to tender all their…

news

TauRx Pharmaceuticals' experimental Alzheimer's drug LMTX failed to improve cognitive and functional skills in patients with mild to moderate Alzheimer's disease, a large, late-stage study showed. But in a perplexing twist, the drug did show a significant benefit in about 15 percent of patients in the trial who were not…

news

Generic competition to cholesterol buster Crestor in the U.S. market pushed second-quarter earnings down by nearly a third at drugmaker AstraZeneca, which is now banking on new cancer medicines to revive its fortunes. Core earnings per share, which exclude some items, fell 31 percent to 83 cents as revenue slid…

news

Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy Gland Pharma - backed by KKR & Co LP - for about $1.4 billion, a person with direct knowledge of the matter said, in India's largest inbound acquisition this year. The deal would be the first major move by the…

news

Eli Lilly and Co on Tuesday reported better-than-expected quarterly sales, fueled by newer drugs, and predicted average annual revenue growth of at least 5 percent through the end of the decade due to its growing roster of medicines. The Indianapolis drugmaker, whose earnings growth resumed last year after three years…